MVLS Covid19 Outputs

McDougall, C. W., Brown, C., Thomson, C., Hanley, N. , Tully, M. A., Quilliam, R. S., Bartie, P. J., Gibson, L. and Oliver, D. M. (2020) From one pandemic to another: emerging lessons from COVID-19 for tackling physical inactivity in cities. Cities and Health, (doi: 10.1080/23748834.2020.1785165) (Early Online Publication)

Kronfeld-Schor, N., Stevenson, T., Nickbakhsh, S. , Schernhammer, E., Dopico, X., Dayan, T., Martinez, M. and Helm, B. (2020) Drivers of infectious disease seasonality: potential implications for COVID-19. Journal of Biological Rhythms, (Accepted for Publication)

Murcia, P. , Streiker, D. , Da Silva Filipe, A., Robertson, D. , Jarrett, R. , Willett, B. , Hosie, M. , Biek, R. , Allan, K. and Weir, W. (2020) Send cat and dog samples to test for SARS-CoV-2. Veterinary Record, 186(17), p. 571. (doi: 10.1136/vr.m2019) (PMID:32451348)

Hanlon, P. et al. (2020) COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study. Wellcome Open Research, 5, 75. (doi: 10.12688/wellcomeopenres.15849.1) (PMID:PPR153916)

Olival, K. J. et al. (2020) Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: a case study of bats. PLoS Pathogens, 16(9), e1008758. (doi: 10.1371/journal.ppat.1008758) (PMID:32881980) (PMCID:PMC7470399)

Addie, D., Houe, L., Maitland, K. , Passantino, G. and Decaro, N. (2020) Effect of cat litters on feline coronavirus infection of cell culture and cats. Journal of Feline Medicine and Surgery, 22(4), pp. 350-357. (doi: 10.1177/1098612x19848167) (PMID:31094626)

Ceron, J. J., Lamy, E., Martinez-Subiela, S., Lopez-Jornet, P., Capela e Silva, F., Eckersall, P. D. and Tvarijonaviciute, A. (2020) Use of saliva for diagnosis and monitoring the SARS-CoV-2: a general perspective. Journal of Clinical Medicine, 9(5), e1491. (doi: 10.3390/jcm9051491)

Hadjiyiannakis, D., Dimitroyannis, D., Eastlake, L., Peedell, C., Tripathi, L., Simcock, R., Vyas, A., Deutsch, E. and Chalmers, A.J. (2020) Personal view: low-dose lung radiotherapy should be evaluated as a treatment for severe COVID-19 lung disease. Clinical Oncology, (doi: 10.1016/j.clon.2020.08.003) (PMID:32829986) (PMCID:PMC7427522) (In Press)

Hanna, C. R. , Robb, K. A. , Blyth, K. G. , Jones, R. J. and Chalmers, A. J. (2020) Clinician attitudes to using low dose radiotherapy to treat COVID-19 lung disease. International Journal of Radiation Oncology, Biology, Physics, (doi: 10.1016/j.ijrobp.2020.12.003) (Early Online Publication)

Boyle, J. G., Walters, M. R. , Jamieson, S. and Durning, S. J. (2020) Clinical reasoning in the wild: premature closure during the COVID-19 pandemic. Diagnosis, 7(3), pp. 177-179. (doi: 10.1515/dx-2020-0061) (PMID:32710716)

Ferguson, K., Quail, N., Kewin, P. and Blyth, K. G. (2020) COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis. BMJ Case Reports, 13(8), e237460. (doi: 10.1136/bcr-2020-237460) (PMID:32747597) (PMCID:PMC7401579)

Faivre-Finn, C. et al. (2020) Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic. Clinical Oncology, 32(8), pp. 481-489. (doi: 10.1016/j.clon.2020.05.001) (PMID:32405158) (PMCID:PMC7218369)

Duffy, C. et al. (2020) Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter. BMJ Open, 7, e000710. (doi: 10.1136/bmjresp-2020-000710) (PMID:33148778) (PMCID:PMC7643431)

Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1)

O'Cathail, S.M. , Gilbert, D.C., Sebag-Montefiore, D. and Muirhead, R. (2020) Challenges and consequences of COVID-19 in the management of anorectal cancer: coming together through social distancing. Clinical Oncology, 32(7), pp. 413-416. (doi: 10.1016/j.clon.2020.04.009) (PMID:32359847) (PMCID:PMC7184022)

Stenvinkel, P., Painer, J., Shiels, P.G. , Bansal, A., Fereidouni, S., Natterson-Horowitz, B., Johnson, R.J. and Miranda, J.J. (2020) SARS-COV-2 and biomimetics: what saves the planet will save our health. Journal of Internal Medicine, (doi: 10.1111/joim.13128) (PMID:32583447) (Early Online Publication)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (Early Online Publication)

Jones, C. M. et al. (2020) Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. British Journal of Cancer, 123(5), pp. 709-713. (doi: 10.1038/s41416-020-0980-x) (PMID:32641867) (PMCID:PMC7341025)

Please see our ICAMS Covid19 Cardiovascular Research pages for all current projects, publications and outputs. 

There seems to be a problem with the publications at the moment. Please try again later.

• Chief Scientist Office. Understanding longer-term health impacts of social distancing and
  behavioural interventions introduced to prevent the spread of infection in the population. Dr Katie Robb (PI) & Professor Rory O’Connor. £37,000.
• Hunt K, Stead M, Purves R, Bunn C, Gray C, Reith G, Wardle H, Dobbie F, Critchlow N, Donnachie A. Transitions to more harmful forms of gambling during Covid-19 pandemic: behaviours and targeted marketing in young people and bettors on sport. ESRC £464,387. Jun 2020-Dec 2021.
• Gray CM, O’Donnell K, Wyke S part of a Scotland-wide consortium of 33 behavioural scientists Protecting population physical & mental health during the coronavirus pandemic: A representative national weekly survey to understand changes. CSO £324,472. May 2020-Nov 2020.
• Shakespeare T, Watson N, Burns N, Pearson C, Wiseman P, Banks M and Kupar H. Disability and Covid 19. The aim of this study is to understand disabled people's experiences during the COVID-19 epidemic, barriers experienced and lessons learned for policy and  practice. £390,000 ESRC COVID-19 Rapid Response research call
• Crampin A, Mwansambo C, Chauma Mwale A, Madise N, Ho A, Mwapasa V, Nyirenda T, Read J, Jewell C, MacPherson P, Price A, Amoah A. SARS-CoV-2 immunoepidemiology in Wellcome-funded urban andrural cohorts in Malawi : generating evidence to inform regional medium and long term decision making. Wellcome £249,544.00
• Hatton, C., Hastings, R, Abbott, D., Beyer, S., Bradshaw, J., Gore, N., Heslop, P., Jahoda, A., Marriot, A., Scior, K., Taggart, L., and Todd, S. Title: The impact of the COVID-19 pandemic on people with learning disabilities and factors associated with better outcomes. MRC award, £763,431 (September 2020- 2021)
• Prof Kate O’Donnell as PI; Dr Sara Macdonald and Dr David Blane as Co-Is. Title: Patient and public understanding of, and preferences for, digital tools to support the Scottish Test, Trace, Isolate, Support programme for COVID-19 infection. DHI/PHS; £30,000. (June – August 2020).
• How has Covid-19 social distancing amplified the mental health vulnerabilities of gay, bisexual and other men who have sex with men (GBM)?  Dr Jamie Frankis, Reader in Health Psychology, GCU, Prof P Flowers, U. Strathclyde; Prof L McDaid, U. Glasgow; Dr D Strongylou, R Kincaid, GCU, J Heng, NHS Glasgow; T Tougher, NHS Lanarkshire; Y Kerr & Dr D Clutterbuck, NHS Lothian; Dr L Wallace, HPS; N Sparling, HIV Scotland.  CSO £49,728 
• Social and health impacts of COVID-19 suppression in vulnerable groups. Prof Sarah Armstrong, Dr Lucy Pickering - CSO £186,869

Link to Covid19 Outputs on SPHSU Website

The Roberson Centre for Biostatistics are involved as co-applicants/partners in the undernoted Covid19-related grants:

• UKRI NIHR - Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: the COVID-HEART study - Prof Colin J Berry, Robertson Centre (Data Management, Statistics, Project Management, ECGs] – Total Grant award £620,076
• Medical Research Scotland – The influence of COVID-19 pandemic on the Scottish congenital heart disease population – Dr Mark Danton, Professor J G Cleland, Professor Alex McConnachie, Ms Sharon Kean – Total Grant Award £20,000
• Medical Research Scotland - Right Ventricular Dysfunction in Ventilated Patients with COVID-19 (COVID-RV) – Dr Ben Shelley, Professor Colin J Berry, Dr Claudia-Martina Messow – Total Grant Award £18,280
• Chief Scientists Office – Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) – Professor Colin J Berry, Professor Alex McConnachie, Ms Sharon Kean – Total Grant Award £47,940
• Medical Research Scotland - 3D Telemedicine: Transforming Patient Communication during Covid-19 – Dr Steven Lo, Robertson Centre [Statistics] - Total Grant Award £19,829

Additional advisory roles and outputs:

• RCB provides technical support for Professor Pell to analyse data in the Glasgow SafeHaven to inform the Health Board’s strategy on COVID-19 ‘shielding’.
• The RCB team has also created several UK national registries (supported by the British Cardiovascular Society) to capture cardiovascular complications and interventions associated with COVID-19,
• Dr Pierpaolo Pellicori (Clinical Senior Lecturer) is leading a Cochrane Rapid Review on cardiovascular complications of COVID-19.

• Professor Andrew Gumley chairs the Scottish Government Covid-19 Mental Health Advisory Group and Professor Rory O’Connor is a member.
• Professor Rory O’Connor co-led the Academy of Medical Sciences and MQ Transforming Mental Health Position Paper published in Lancet Psychiatry on setting the mental health science research priorities for the COVID-19 pandemic.
• Professor Rory O’Connor was part of the COVID-19 International Suicide Prevention Research Collaboration which highlighted the strategic response for suicide prevention, also published in Lancet Psychiatry.
• Professor Rory O’Connor and Jack Melson worked closely with the Scottish Government on its flagship Distress Brief Intervention Programme and developed all of the intervention and training materials. In May 2020, the First Minister decided to scale up the DBI programme nationally to deal with the impact of Covid-19.
• Professor Jill Pell is a member of the Scottish Government’s Covid-19 Advisory Group and the testing strategy sub-group.
• Professor Andrew Gumley and Professor John Cleland are members of the CSO / NRS Restart Strategic Advisory Group.
• Claire Orange and Professor Julie Brittenden in RESTART group
• Professor Danny Mackay is member of the UKRI-BBSRC COVID-19 Cohort of Experts.
• Professor Kate O'Donnell is member of the Scottish Government Expert Reference Group on Ethnicity COVID-19.
• Professor Vittal Katikireddi is Co-Chair of the Scottish Government Expert Reference Group on Ethnicity COVID-19.
• Dr Janet Bouttell, Professor Olivia Wu, Professor Kate O’Donnell, Dr David Blane and Dr Bhautesh Jani are all part of the working group with SIGN and Health Improvement Scotland to produce evidence-based guidance for Primary Care.
• Dr David Ross provides COVID-19 advice and support to UK Defence, the Army and NATO and is lead researcher looking at the impact of COVID-19 lockdown and social isolation in soldiers.
  

SPHSU

• Dr Elise Whitley is a member of Public Health Scotland’s Mental Health Cell and currently contributing to priority setting for future work and advising on likely data sources for monitoring.
• Dr Eric Silverman is a member of Covid-19 Healthcare Coalition which is developing a decision-support dashboard intended to help policy-makers in the US to monitor the progress of the pandemic at the state and county level throughout the country.
• Professor Rich Mitchell and Dr Jonathan Olsen are on Public Health Scotland's Social and System Recovery: Environments and Spaces Group. Rich is leading their Evidence and Data subgroup.
  The group is currently exploring the implications of the COVID-19 pandemic for open spaces, parks, streets, public spaces.
• Ms Ruth Dundas is part of The Scottish COVID-19 Response Consortium (SCRC) - a group of epidemiologists, mathematical modellers, data scientists, software developers and other scientists that have come together to develop new models to help inform the control of COVID-19.
• One of the key groups identified by RAMP to develop a wider range of pandemic models is the University of Glasgow led Scottish COVID-19 Response Consortium. SPHSU is involved in curating data to support model specification and calibration, and we will be increasingly involved in model design and programming.
• Dr Vittal Katikireddi is co-chair and Dr Rachel Thomson, Dr Theocharis Kromydas and Dr Peter Craig are members of a group convened by Public Health Scotland to advise the Scottish Government and other stakeholders (e.g. CoSLA, Social Security Scotland) on the impacts of the COVID-19 response on health and health inequalities that arise through economic and related pathways, and on actions that may mitigate negative impacts and enhance positive impacts. The group has published a briefing looking at protecting the health of the working-age population as lockdown reduces. 

INS (International Neuropsychological Society) Newsletter

• Narayanan, J., Evans, J.J., & Wilson, B.A., (2020) Balint’s syndrome as a consequence of COVID-19: A case from Southern India. INS News: International Neuropsychological Society Member Newsletter, Issue 3, p27-31

BMJ Editorial

• Safely returning clinically vulnerable people to work.  Ewan Macdonald, honorary professor of occupational medicine,  John Middleton, honorary professor of public health,  Drushca Lalloo, honorary clinical senior lecturer,  Trisha Greenhalgh, professor of primary care research

Public Health Scotland Report

• Flynn R, Riches E, Reid G, Rosenberg S, Niedzwiedz C. Rapid review of the impact of COVID-19 on mental health. Edinburgh: Public Health Scotland; 2020
  
  

Please follow this link for the Centre for Virus Research's response to Covid19. 

The Centre for Virus Research (CVR) has also contributed to this year's online Glasgow Science Festival 2020: Science on the Sofa.

• Professor David Robertson on the evolutionary origins of SARS-CoV-2
• Professor Emma Thomson on where SARS-CoV-2 in Scotland came from and a potential vaccine
• Dr Janet Scott on long-term health and psychosocial implications of Covid19 (#LongCovid)
• Dr Antonia Ho on understanding how Covid19 affects the body in Scotland and Malawi
• Dr Ana Da Silva Filipe on sequencing the genome of SARS-CoV-2
• Dr Agnieszka Szemiel on growing the virus in a high containment lab

Zumla, A., Alagaili, A. N., Cotten, M. and Azhar, E. I. (2016) Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV). BMC Medicine, 14, 132. (doi: 10.1186/s12916-016-0686-3) (PMID:27604081) (PMCID:PMC5015245)

McInnes, I. B. (2020) COVID-19 and rheumatology: first steps towards a different future? Annals of the Rheumatic Diseases, 79(5), pp. 551-552. (doi: 10.1136/annrheumdis-2020-217494) (PMID:32299844)

Memish, Z. A. et al. (2014) Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerging Infectious Diseases, 20(6), pp. 1012-1015. (doi: 10.3201/eid2006.140402) (PMID:24857749) (PMCID:PMC4036761)

Morgan, D. C. et al. (2021) Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation. Peptide Science, (doi: 10.1002/pep2.24217) (Early Online Publication)

Mehta, P., Porter, J. C., Manson, J. J., Isaacs, J. D., Openshaw, P. J.M., McInnes, I. B. , Summers, C. and Chambers, R. C. (2020) Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities. Lancet Respiratory Medicine, 8(8), pp. 822-830. (doi: 10.1016/S2213-2600(20)30267-8) (PMID:32559419)

Pollock, D. D. et al. (2020) Viral CpG deficiency provides no evidence that dogs were intermediate hosts for SARS-CoV-2. Molecular Biology and Evolution, 37(9), pp. 2706-2710. (doi: 10.1093/molbev/msaa178) (PMID:32658964) (PMCID:PMC7454803)

Hughes, E. C. et al. (2020) SARS-CoV-2 serosurveillance in a patient population reveals differences in virus exposure and antibody-mediated immunity according to host demography and healthcare setting. Journal of Infectious Diseases, (doi: 10.1093/infdis/jiaa788) (PMID:33367847) (Early Online Publication)

Cotten, M. et al. (2013) Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet, 382(9909), pp. 1993-2002. (doi: 10.1016/S0140-6736(13)61887-5) (PMID:24055451) (PMCID:PMC3898949)

Nickbakhsh, S. , Ho, A. , Marques, D. F.P., McMenamin, J., Gunson, R. N. and Murcia, P. R. (2020) Epidemiology of seasonal coronaviruses: establishing the context for the emergence of coronavirus disease 2019. Journal of Infectious Diseases, 222(1), pp. 17-25. (doi: 10.1093/infdis/jiaa185) (PMID:32296837) (PMCID:PMC7184404)

Cevik, M., Bamford, C. and Ho, A. (2020) COVID-19 Pandemic – a focused review for clinicians. Clinical Microbiology and Infection, 26(7), pp. 842-847. (doi: 10.1016/j.cmi.2020.04.023) (PMID:32344166) (PMCID:PMC7182753)

Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1)

Voysey, M. et al. (2020) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet, (doi: 10.1016/S0140-6736(20)32661-1) (Early Online Publication)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (Early Online Publication)

Murcia, P. , Streiker, D. , Da Silva Filipe, A., Robertson, D. , Jarrett, R. , Willett, B. , Hosie, M. , Biek, R. , Allan, K. and Weir, W. (2020) Send cat and dog samples to test for SARS-CoV-2. Veterinary Record, 186(17), p. 571. (doi: 10.1136/vr.m2019) (PMID:32451348)

Kronfeld-Schor, N., Stevenson, T., Nickbakhsh, S. , Schernhammer, E., Dopico, X., Dayan, T., Martinez, M. and Helm, B. (2020) Drivers of infectious disease seasonality: potential implications for COVID-19. Journal of Biological Rhythms, (Accepted for Publication)

McInnes, I. (2020) Response to: 'Hydroxychloroquine shortages during the COVID-19 pandemic' by Mendel et al. Annals of the Rheumatic Diseases, (doi: 10.1136/annrheumdis-2020-217954) (PMID:32434826) (Early Online Publication)

Kiyuka, P. K. et al. (2018) Human coronavirus NL63 molecular epidemiology and evolutionary patterns in rural coastal Kenya. Journal of Infectious Diseases, 217(11), pp. 1728-1739. (doi: 10.1093/infdis/jiy098) (PMID:29741740) (PMCID:PMC6037089)

Maguire, D. et al. (2020) Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection. Journal of Translational Medicine, 18, 354. (doi: 10.1186/s12967-020-02524-4) (PMID:32933530) (PMCID:PMC7491021)

Guzik, T. J. et al. (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research, 116(10), pp. 1666-1687. (doi: 10.1093/cvr/cvaa106) (PMID:32352535) (PMCID:PMC7197627)

da Silva, S. J. R., da Silva, C. T. A., Guarines, K. M., Mendes, R. P. G., Pardee, K., Kohl, A. and Pena, L. (2020) Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19. ACS Infectious Diseases, 6(9), pp. 2319-2336. (doi: 10.1021/acsinfecdis.0c00274) (PMID:32786280) (PMCID:PMC7441751)

Harrison, E. M. et al. (2020) Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients. SSRN Electronic Journal, (doi: 10.2139/ssrn.3618215) (Submitted)

Pairo-Castineira, E. et al. (2020) Genetic mechanisms of critical illness in Covid-19. Nature, (doi: 10.1038/s41586-020-03065-y) (PMID:33307546) (Early Online Publication)

Knight, S. R. et al. (2020) Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. British Medical Journal, 2020, 370. (doi: 10.1136/bmj.m3339) (PMID:32907855)

Memish, Z. A., Cotten, M. , Watson, S. J., Kellam, P., Zumla, A., Alhakeem, R. F., Assiri, A., Al Rabeeah, A. A. and Al-Tawfiq, J. A. (2014) Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. International Journal of Infectious Diseases, 23, pp. 63-68. (doi: 10.1016/j.ijid.2014.03.1372) (PMID:24699184) (PMCID:PMC4441753)

Berto, A. et al. (2018) Detection of potentially novel paramyxovirus and coronavirus viral RNA in bats and rats in the Mekong Delta region of southern Viet Nam. Zoonoses and Public Health, 65(1), pp. 30-42. (doi: 10.1111/zph.12362) (PMID:28418192) (PMCID:PMC5811810)

Boni, M. F., Lemey, P., Jiang, X., Lam, T. T.-Y., Perry, B. W., Castoe, T. A., Rambaut, A. and Robertson, D. L. (2020) Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nature Microbiology, 5(11), pp. 1408-1417. (doi: 10.1038/s41564-020-0771-4) (PMID:32724171)

Assiri, A. et al. (2013) Hospital outbreak of Middle East respiratory syndrome coronavirus. New England Journal of Medicine, 369(5), pp. 407-416. (doi: 10.1056/NEJMoa1306742) (PMID:23782161) (PMCID:PMC4029105)

Barry, M. et al. (2020) Nosocomial outbreak of the Middle East Respiratory Syndrome coronavirus: a phylogenetic, epidemiological, clinical and infection control analysis. Travel Medicine and Infectious Disease, 37, 101807. (doi: 10.1016/j.tmaid.2020.101807) (PMID:32599173) (PMCID:PMC7319941)

Docherty, A. B. et al. (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. British Medical Journal, 369, m1985. (doi: 10.1136/bmj.m1985) (PMID:32444460)

Banerjee, A. K. et al. (2020) SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell, (doi: 10.1016/j.cell.2020.10.004) (PMID:33080218) (PMCID:PMC7543886)

Sabir, S. R., Thomson, E. C. , Guzik, T. J., D’Acquisto, F. and Maffia, P. (2020) COVID-19: the new immune challenge. Frontiers for Young Minds, 8, 582971. (doi: 10.3389/frym.2020.582971)

Cevik, M., Tate, M., Lloyd, O., Maraolo, A. E., Schafers, J. and Ho, A. (2020) SARS-CoV-2, SARS-CoV-1 and MERS-CoV viral load dynamics, duration of viral shedding and infectiousness: a systematic review and meta-analysis. Lancet Microbe, (doi: 10.1016/S2666-5247(20)30172-5) (Early Online Publication)

MacLean, O. A., Orton, R. J. , Singer, J. B. and Robertson, D. L. (2020) No evidence for distinct types in the evolution of SARS-CoV-2. Virus Evolution, 6(1), veaa034. (doi: 10.1093/ve/veaa034)

Swann, O. V. et al. (2020) Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. British Medical Journal, 370, m3249. (doi: 10.1136/bmj.m3249) (PMID:32960186) (PMCID:PMC7488201)

Silva, S. J. R. d., Germano Mendes, R. P., Alves da Silva, C. T., Lorusso, A., Kohl, A. and Pena, L. (2020) Insights into SARS-CoV-2, the coronavirus underlying COVID-19: recent genomic data and the development of reverse genetics systems. Journal of General Virology, 101(10), pp. 1021-1024. (doi: 10.1099/jgv.0.001458) (PMID:32579100) (PMCID:PMC7660456)

Volz, E. et al. (2020) Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity. Cell, (doi: 10.1016/j.cell.2020.11.020) (PMID:33275900) (PMCID:PMC7674007) (Early Online Publication)

Cotten, M. et al. (2014) Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. mBio, 5(1), e01062-13. (doi: 10.1128/mBio.01062-13) (PMID:24549846) (PMCID:PMC3944817)

Sattar, N. , McInnes, I. B. and McMurray, J. J.V. (2020) Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation, 142(1), pp. 4-6. (doi: 10.1161/CIRCULATIONAHA.120.047659) (PMID:32320270)

Zumla, A. et al. (2016) Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential. International Journal of Infectious Diseases, 47, pp. 5-9. (doi: 10.1016/j.ijid.2016.06.012) (PMID:27321961)

Morgan, D. C. et al. (2021) Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation. Peptide Science, (doi: 10.1002/pep2.24217) (Early Online Publication)

Hart, A. (2020) Cover illustration: "Lockdown" mural, Bath Street, Glasgow, by the.rebel.bear Unshackling Plastic Surgery from COVID-19. Journal of Plastic, Reconstructive and Aesthetic Surgery, 73(6), pp. 1009-1011. (doi: 10.1016/j.bjps.2020.05.082) (PMID:32553186) (PMCID:PMC7293883)

Rooksby, M. , Furuhashi, T. and McLeod, H. J. (2020) Hikikomori: a hidden mental health need following the COVID-19 pandemic. World Psychiatry, 19(3), pp. 399-400. (doi: 10.1002/wps.20804) (PMID:32931118)